IntroductionImmune-checkpoint inhibitors are effective in various advanced cancers. Type 1 diabetes mellitus induced by them (ICI-T1DM) is a serious complication requiring prompt insulin treatment. but the immunological mechanism behind it is unclear. MethodsWe examined amino acid polymorphisms in human histocompatibility leukocyte antigen (HLA) molecules and investigated proinsulin e... https://www.roneverhart.com/SAAB-9-3-I-98-02-Frontlykt-Hoyre/